Cargando…
The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis
The lethal disease alveolar echinococcosis (AE) is caused by the metacestode stage of the fox tapeworm Echinococcus multilocularis. Current chemotherapeutical treatment of AE relies on albendazole and mebendazole, with the caveat that these compounds are not parasiticidal. Drugs have to be taken for...
Autores principales: | Lundström-Stadelmann, Britta, Rufener, Reto, Ritler, Dominic, Zurbriggen, Raphael, Hemphill, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034016/ https://www.ncbi.nlm.nih.gov/pubmed/32095613 http://dx.doi.org/10.1016/j.fawpar.2019.e00040 |
Ejemplares similares
-
Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds
por: Ritler, Dominic, et al.
Publicado: (2017) -
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis
por: Stadelmann, Britta, et al.
Publicado: (2016) -
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis
por: Lundström-Stadelmann, Britta, et al.
Publicado: (2020) -
Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis
por: Rufener, Reto, et al.
Publicado: (2018) -
Treatment of echinococcosis: albendazole and mebendazole – what else?
por: Hemphill, Andrew, et al.
Publicado: (2014)